Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Related Posts
Eli Lilly’s Tirzepatide Shows Reduction in Risk of Heart Failure Outcomes
Image Credit: © ckybe – stock.adobe.com According to new data revealed by Eli Lilly, tirzepatide significantly improved heart failure symptoms…
Set the Course for a More Engaging & Productive Patient & Clinical Trial Site Journey
Sponsored by uMotif In this video, uMotif CEO Steve Rosenberg discusses key trends shaping the clinical trial landscape, including CRO…
Keytruda Combination Falls Short of Disease-Free Survival Primary Endpoint in Phase III Trial for High-Risk Endometrial Cancer
Image credit: MdBabul | stock.adobe.com Keytruda (pembrolizumab; Merck) plus chemotherapy as adjuvant therapy, with or without radiotherapy, in the treatment of…